Hepatocyte Mitochondrial Dynamics and Bioenergetics in Obesity-Related Non-Alcoholic Fatty Liver Disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2162-4968
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Hepatocyte Mitochondrial Dynamics and Bioenergetics in Obesity-Related Non-Alcoholic Fatty Liver Disease ; day:2 ; month:5 ; year:2022 ; pages:1-18
Current obesity reports ; (2.5.2022), 1-18
- Urheber
-
Legaki, Aigli-Ioanna
Moustakas, Ioannis I.
Sikorska, Michalina
Papadopoulos, Grigorios
Velliou, Rallia-Iliana
Chatzigeorgiou, Antonios
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s13679-022-00473-1
- URN
-
urn:nbn:de:101:1-2022071021365726984236
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:33 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Legaki, Aigli-Ioanna
- Moustakas, Ioannis I.
- Sikorska, Michalina
- Papadopoulos, Grigorios
- Velliou, Rallia-Iliana
- Chatzigeorgiou, Antonios
- SpringerLink (Online service)
Ähnliche Objekte (12)
Hepatocyte Mitochondrial Dynamics and Bioenergetics in Obesity‑Related Non‑Alcoholic Fatty Liver Disease
Hepatocyte expressed chemerin-156 does not protect from experimental non-alcoholic steatohepatitis
Hepatocyte caveolin-1 functions on metabolic gene signatures and in non-alcoholic fatty liver disease
Hepatocyte-specific loss of GPS2 in mice reduces non-alcoholic steatohepatitis via activation of PPARα
The p-STAT3/ANXA2 axis promotes caspase-1-mediated hepatocyte pyroptosis in non-alcoholic steatohepatitis
Non-alcoholic fatty liver disease in mice with hepatocyte-specific deletion of mitochondrial fission factor
Hepatocyte-specific NR5A2 deficiency induces pyroptosis and exacerbates non-alcoholic steatohepatitis by downregulating ALDH1B1 expression
Analysis of non-alcoholic beverages
Non-alcoholic fatty liver disease
The effect of non-alcoholic steatosis hepatitis on weight-loss and resolution of obesity-related comorbidities after bariatric surgery
Atg5-deficient mesenchymal stem cells protect against non-alcoholic fatty liver by accelerating hepatocyte growth factor secretion
The Effect of Non-Alcoholic Fatty Liver Disease on Weight Loss and Resolution of Obesity-Related Disorders After Bariatric Surgery
Hepatocyte Mitochondrial Dynamics and Bioenergetics in Obesity‑Related Non‑Alcoholic Fatty Liver Disease
Hepatocyte expressed chemerin-156 does not protect from experimental non-alcoholic steatohepatitis
Hepatocyte caveolin-1 functions on metabolic gene signatures and in non-alcoholic fatty liver disease
Hepatocyte-specific loss of GPS2 in mice reduces non-alcoholic steatohepatitis via activation of PPARα
The p-STAT3/ANXA2 axis promotes caspase-1-mediated hepatocyte pyroptosis in non-alcoholic steatohepatitis
Non-alcoholic fatty liver disease in mice with hepatocyte-specific deletion of mitochondrial fission factor
Hepatocyte-specific NR5A2 deficiency induces pyroptosis and exacerbates non-alcoholic steatohepatitis by downregulating ALDH1B1 expression
Analysis of non-alcoholic beverages
Non-alcoholic fatty liver disease
The effect of non-alcoholic steatosis hepatitis on weight-loss and resolution of obesity-related comorbidities after bariatric surgery
Atg5-deficient mesenchymal stem cells protect against non-alcoholic fatty liver by accelerating hepatocyte growth factor secretion
The Effect of Non-Alcoholic Fatty Liver Disease on Weight Loss and Resolution of Obesity-Related Disorders After Bariatric Surgery
Hepatocyte Mitochondrial Dynamics and Bioenergetics in Obesity‑Related Non‑Alcoholic Fatty Liver Disease
Hepatocyte expressed chemerin-156 does not protect from experimental non-alcoholic steatohepatitis
Hepatocyte caveolin-1 functions on metabolic gene signatures and in non-alcoholic fatty liver disease
Hepatocyte-specific loss of GPS2 in mice reduces non-alcoholic steatohepatitis via activation of PPARα
The p-STAT3/ANXA2 axis promotes caspase-1-mediated hepatocyte pyroptosis in non-alcoholic steatohepatitis
Non-alcoholic fatty liver disease in mice with hepatocyte-specific deletion of mitochondrial fission factor
Hepatocyte-specific NR5A2 deficiency induces pyroptosis and exacerbates non-alcoholic steatohepatitis by downregulating ALDH1B1 expression
Analysis of non-alcoholic beverages
Non-alcoholic fatty liver disease
The effect of non-alcoholic steatosis hepatitis on weight-loss and resolution of obesity-related comorbidities after bariatric surgery
Atg5-deficient mesenchymal stem cells protect against non-alcoholic fatty liver by accelerating hepatocyte growth factor secretion